
Aristo Biotech and Life Science IPO GMP, Price, Dates & Allotment Details 2023

Aristo Biotech & Life Sciences IPO will open on January 16 and close on January 19, 2023. As per the DRHP filed with SEBI, the company intends to raise approximately ₹ 13.05 crore through this public offering, consisting of 1,812,800 shares of face value of ₹ 10 each. Which will be issued at a price of ₹ 72 per share.
Incorporated in 2005. Company is an agrochemical company engaged in the manufacturing, formulation, supplying, packaging, and job work services of various pesticides such as insecticides, herbicides, fungicides, plant growth regulators, and a variety of other agrochemicals for India as well as for export.
Agrochemical industries are a very diversified field and deal with the production and distribution of pesticides and fertilisers to increase crop yields. Pesticides and agrochemicals (sometimes known as crop protection products or pesticides) are used to protect crops against weeds, insects, and illnesses. Currently, the company has 182 products registered with CIB & RC for manufacturing and sales.
It is an ISO 9001:2015-certified company for its quality management system. The company’s diversified product portfolio can be classified as herbicides, weedicides, fungicides, plant growth regulators, and insecticides. It sells its goods in 20 Indian states and 15 other countries.
Objects of the Issue
The company proposes to utilize the net proceeds of the Fresh Issue towards funding the following objects:
- To Meet Working Capital Requirement
- General Corporate Purpose
- To Meet the Issue Expenses
Financial Highlights (Consolidated)
Particulars | Period ended on 30th September 2022 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
---|---|---|---|---|
Net Worth | 1743.15 | 1484.25 | 1338.08 | 1230.51 |
Total Assets | 10869.14 | 7700.16 | 8141.73 | 8785.12 |
Total Revenue | 12907.49 | 16603.29 | 16722.96 | 20123.94 |
Profit After Tax | 258.90 | 146.17 | 107.57 | 100.74 |
ALSO READ
Best Stock To Buy During Covid Pandemic
As you must be seeing in the news right now, the Covid pandemic is knocking again in the world. We have seen earlier that the impact of the Covid epidemic falls on every sector of the economy. READ MORE
Aristo Biotech and Life Science IPO – Details
According to the DRHP filed with SEBI, the company plans to issue 1,812,800 shares of face value of ₹ 10 each, aggregating up to ₹ 13.05 crore.
Issue Type | Fixed Price Issue IPO |
IPO Price | ₹ 72 per share |
Face Value | ₹ 10 per share |
Market Lot | 1,600 shares |
Issue Size | 1,812,800 shares of ₹ 10 (Aggregating up to ₹ 13.05 Crore) |
Fresh Issue | 1,812,800 shares of ₹ 10 (Aggregating up to ₹ 13.05 Crore) |
NII (HNI) Shares Offered | 50% of the Net Issue |
Retail Shares Offered | 50% of the Net Issue |
Listing At | NSE SME |
Promoters | 1. Mr. Narendra Singh Barhat, 2. Mrs. Kusum Narendra Singh Barhat 3. Mr. Ketankumar Harkantbhai Joshi |
GMP – Aristo Biotech and Life Science IPO
Aristo Biotech and Life Science IPO GMP, or Grey Market Premium, are available here. The IPO GMP Premium updated day by day for IPOs’ running periods, and the GMP rates fluctuate and became stable some time later. The GMP rates are not 100% guaranteed. Please click here for GMP details.
Tentative Dates – Aristo Biotech and Life Science IPO
Aristo Biotech and Life Science IPO opens on January 16 and closes on January 19, 2023.
Opening Date | January 16, 2023 |
Closing Date | January 19, 2023 |
Basis of Allotment | January 24, 2023 |
Initiation of Refunds | January 15, 2023 |
Credit of shares to Demat A/c | January 26, 2023 |
Listing Date | January 27, 2023 |
Lot Size – Aristo Biotech and Life Science IPO
The Aristo Biotech and Life Science IPO lot size is 1,600 shares. A retail-individual investor can apply for up to 1 lot i.e. 1,600 shares of ₹ 115,200.
Applications | Lots | Shares | Amount |
---|---|---|---|
Retail (Minimum) | 1 | 1,600 | ₹ 115,200 |
Retail (Maximum) | 1 | 1,600 | ₹ 115,200 |
HNI (Minimum) | 2 | 3,200 | ₹ 230,400 |
Promoters Holdings – Aristo Biotech and Life Science IPO
Pre-issue Shares Holdings | 100% |
Post-issue Shares Holdings | 73.37% |
ALSO READ
Glenmark Pharmaceuticals Limited Share Price Targets 2023, 2024, 2025, 2026, 2028, 2030 & 2040
This post is about Glenmark Pharmaceuticals Ltd.’s share price targets in the coming years. India has the most pharmaceutical manufacturing facilities. The Indian Pharmaceutical Industry READ MORE
SWOT Analysis – Aristo Biotech and Life Science IPO
STRENGTHS | WEAKNESSES |
---|---|
1. Existing client relationship. 2. Quality Assurance and Standards. 3. Scalable Business Model. 4. Cost effective production and timely fulfillment of orders. | 1. There are outstanding legal proceedings involving the company, directors, and promoters. 2. Climate conditions and cyclicality affect the Aristo Biotech and Life Science business. 2. The company’s top 10 customers contribute the majority of its revenues. |
OPPORTUNITIES | THREATS |
1. A rise in agricultural demand is propelling the growth of agrochemicals in India. 2. The Indian chemicals industry was worth US$ 178 billion in 2019 and is expected to be worth US$ 304 billion by 2025, growing at a 9.3% CAGR. 3. The demand for chemicals is expected to expand by 9% per year by 2025. | 1. Company failure to adapt to technological development or industry trends. 2. Competitions from organized and unorganized players. |
Miscellaneous Information
Download Prospectus (PDF) | IPO DRHP IPO RHP |
Company Contact Information | Aristo Bio-Tech and Life Science Limited E-24,25,26, G.I.D.C. Manjusar, Ta. Savli, Vadodara – 391775 Phone: +91-2667-264843 Email: [email protected] Website: http://www.aristobiotech.com/ |
IPO Registrar | Link Intime India Private Ltd Phone: +91-22-4918 6270 Email: [email protected] Website: https://linkintime.co.in/ |
IPO Lead Manager(s) | Beeline Capital Advisors Pvt Ltd |
FAQ’s
What is the Aristo Biotech and Life Science IPO price?
The Aristo Biotech and Life Science IPO price is ₹ 72 per share.
What will be the Aristo Biotech and Life Science IPO lot size?
One lot of Aristo Biotech and Life Science IPO contains 1,600 shares of ₹ 115,200.
What minimum lot size can retail investors subscribe to?
The minimum investment size is one lot for retail investors.
When will Aristo Biotech and Life Science IPO list on exchanges?
The Aristo Biotech and Life Science IPO shares listing date is January 27, 2023.
How many shares in Aristo Bio-Tech and Lifescience IPO Offer are reserved for HNIs and retail investors?
The investors’ portion for NII (HNI) – 50%, and Retail – 50%.
Thank you for being of assistance to me. I really loved this article.